middl
east
respiratori
syndrom
coronaviru
merscov
novel
human
coronaviru
figur
emerg
saudi
arabia
rapidli
spread
wordwid
caus
continu
outbreak
signific
mortal
morbid
novemb
world
health
organ
report
laboratoryconfirm
case
infect
merscov
mersassoci
death
fatal
rate
countri
avail
onlin
http
wwwwhointemergenciesmerscoven
merscov
use
dipeptidyl
also
name
typeii
transmembran
glycoprotein
cellular
receptor
infect
human
caus
sever
respiratori
diseas
sever
complic
includ
renal
failur
even
multiorgan
failur
howev
licens
vaccin
effect
therapeut
merscov
infect
approv
us
food
drug
administr
fda
call
urgent
develop
effect
therapeut
merscov
infect
clinic
use
similar
coronavirus
merscov
envelop
positivesens
singlestrand
rna
viru
belong
lineag
c
betacoronaviru
famili
coronavirida
merscov
display
spike
protein
type
transmembran
glycoprotein
envelop
membran
surfac
trimer
state
protein
contain
two
subunit
subunit
subunit
recogn
bind
cellular
receptor
mediat
viral
cellular
membran
fusion
interact
receptorbind
domain
rbd
receptor
host
cell
surfac
induc
structur
chang
includ
insert
ntermin
fusion
peptid
host
cell
membran
format
homotrim
heptad
repeat
helic
expos
three
hydrophob
groov
surfac
bind
three
heptad
repeat
molecul
hydrophob
groov
trimer
form
sixhelix
bundl
bring
viral
cell
membran
close
togeth
fusion
final
merscov
releas
genet
materi
target
cell
figur
disrupt
process
format
inhibit
membran
fusion
abolish
viral
infect
previou
studi
found
peptid
deriv
merscov
region
could
prevent
format
fusion
core
competit
bind
block
nativ
interact
figur
effect
sarscov
infect
sarscov
peptid
fail
inhibit
merscov
infect
suggest
specif
inibit
merscov
infect
whether
novel
potent
peptid
fusion
inhibitor
develop
merscov
coronaviru
region
still
unclear
although
camel
intermedi
host
transmiss
merscov
bat
like
origin
sourc
serv
natur
host
phylogenet
merscov
close
relat
tylonycteri
sp
bat
cov
tybatcov
figur
similar
merscov
also
harbor
abil
use
human
receptor
infect
target
cell
herein
identifi
peptid
deriv
region
could
bind
merscov
peptid
mimic
interact
merscov
region
form
stabl
moreov
peptid
exhibit
signific
inhibitori
activ
merscov
smediat
fusion
assay
pseudoviru
infect
assay
even
potenc
report
peptid
taken
togeth
peptid
could
consid
candid
develop
antimerscov
agent
clinic
use
cell
obtain
chines
academi
scienc
cell
bank
shanghai
china
cell
line
cultur
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
fb
plasmid
includ
mutat
paaviressgfp
construct
laboratori
peptid
synthes
karebay
biochem
monmouth
junction
nj
usa
hplc
puriti
averag
hydrophil
peptid
predict
use
onlin
peptidecalcul
program
avail
onlin
http
wwwbachemcomservicesupportpeptidecalcul
phylogenet
tree
construct
use
access
number
util
phylogenet
analysi
follow
merscov
ibv
circular
dichroism
spectra
nm
collect
spectropolarimet
jasco
inc
tokyo
japan
evalu
secondari
structur
individu
peptid
complex
dissolv
phosphatebuff
salin
pb
final
concentr
ellipt
valu
deg
nm
taken
thermal
denatur
peptid
complex
monitor
nm
thermal
gradient
min
midpoint
thermal
unfold
transit
tm
valu
acquir
jasco
softwar
util
nativ
polyacrylamid
gel
electrophoresi
npage
conduct
describ
elsewher
briefli
peptid
pb
incub
respect
min
use
pb
control
load
trisglycin
gel
tricin
glycin
run
buffer
ph
final
stain
perform
coomassi
blue
imag
visual
fluorchem
imag
system
alpha
innotechproteinsimpl
assay
merscov
proteinmedi
fusion
perform
describ
elsewher
briefli
cell
transient
coexpress
merscov
protein
gfp
protein
cell
surfac
cytoplasm
respect
use
effector
cell
cell
use
target
cell
effector
cell
cell
per
well
target
cell
cell
per
well
cocultur
well
flatbottom
plate
h
presenc
absenc
peptid
indic
concentr
final
fuse
unfus
cell
visual
photograph
count
invert
fluoresc
microscop
nikon
eclips
ti
pb
without
peptid
use
inhibit
control
median
inhibitori
concentr
calcul
use
calcusyn
softwar
packag
merscov
pseudoviru
describ
previou
studi
briefli
cotransfect
cell
plasmid
without
mutat
plasmid
encod
envdefect
luciferaseexpress
pseudovirus
supernat
collect
h
posttransfect
quantifi
level
lentiviru
target
cell
preplat
plate
cell
per
well
merscov
pseudoviru
premix
peptid
indic
concentr
incub
min
pb
use
inhibit
control
mixtur
ad
cell
replac
fresh
medium
h
postinfect
incub
addit
h
transduc
cell
lyse
detect
rel
light
unit
rlu
accord
luciferas
assay
system
manual
promega
madison
wi
usa
timeofaddit
assay
conduct
describ
previou
studi
briefli
cell
plate
plate
incub
merscov
psv
peptid
final
concentr
ad
h
postinfect
cell
lyse
h
later
determin
entri
inhibit
ratio
peptid
ad
cell
follow
incub
min
respect
cell
wash
pb
remov
unbound
peptid
cell
wash
use
control
follow
addit
merscov
pseudoviru
cocultur
day
cell
lyse
test
inhibitori
activ
peptid
cytotox
peptid
cell
measur
follow
instruct
manual
provid
cell
count
dojindo
kumamoto
kyushu
japan
briefli
peptid
indic
concentr
mix
target
cell
well
plate
coincub
h
cultur
medium
replac
fresh
cell
medium
solut
addit
incub
h
final
absorb
detect
nm
previou
studi
crystal
fusion
core
structur
merscov
subunit
design
peptid
base
fusion
structur
peptid
mimic
interact
region
form
multipl
sequenc
align
merscov
protein
subunit
found
subunit
also
harbor
fusion
peptid
fp
residu
domain
residu
domain
residu
transmembran
domain
residu
intracellular
domain
design
span
residu
peptid
span
residu
respect
figur
similar
three
peptid
contain
helic
region
contain
differ
amino
acid
figur
howev
residu
helic
region
fulli
merscov
helic
region
respons
interact
g
e
residu
region
correspondingli
suggest
peptid
might
crosstarget
merscov
region
investig
whether
could
interact
mimic
region
determin
interact
use
npage
coincub
pb
respect
sampl
load
trisglycin
gel
electrophoresi
shown
figur
individu
peptid
move
lowest
part
gel
nativ
electrophoresi
mainli
carri
neg
charg
contrari
posit
charg
could
move
gel
meanwhil
mixtur
peptid
show
new
band
upper
part
gel
lane
confirm
three
peptid
could
inde
bind
subsequ
assess
abil
peptid
bind
merscov
region
therebi
allow
us
detect
interact
deriv
merscov
region
saw
interact
three
peptid
form
new
band
npage
well
figur
e
suggest
peptid
could
crosstarget
merscov
region
character
interact
peptid
use
circular
dichroism
cd
determin
secondari
structur
peptid
complex
shown
figur
peptid
exhibit
low
structur
wherea
cd
spectrum
complex
display
characterist
structur
ie
doubl
neg
peak
nm
possess
helic
respect
consist
previou
studi
complex
show
high
thermost
tm
valu
similarli
complex
form
peptid
also
possess
strong
thermost
tm
valu
rang
figur
result
show
three
peptid
bind
form
format
good
stabil
among
exhibit
highest
bind
affin
form
suggest
alon
might
potent
antimerscov
effect
determin
whether
peptid
could
inhibit
merscov
smediat
fusion
test
merscov
smediat
fusion
assay
gfp
effector
cell
diffus
target
cell
fuse
cell
show
larger
size
weaker
fluoresc
unfus
effector
cell
similar
peptid
could
effect
inhibit
merscov
smediat
fusion
concentr
respect
figur
b
tabl
howev
show
fusioninhibitori
activ
compar
wherea
show
potent
inhibitori
activ
fact
deriv
merscov
region
indic
good
candid
develop
potent
antimerscov
agent
assess
antimerscov
activ
peptid
test
use
merscov
pseudoviru
infect
assay
abl
mimic
entri
process
authent
merscov
wide
use
basic
antivir
research
peptid
inhibit
entri
merscov
dosedepend
manner
figur
tabl
respect
manner
compar
wherea
neither
exhibit
inhibitori
activ
result
timeofaddit
assay
indic
inhibitori
activ
pseudotyp
merscov
infect
significantli
decreas
peptid
ad
cell
h
postinfect
figur
suggest
peptid
target
viral
fusion
entri
stage
base
numer
epidemiolog
studi
research
found
mutant
site
spike
protein
merscov
particular
strong
posit
select
subunit
importantli
locat
merscov
region
target
site
peptid
fusion
inhibitor
includ
peptid
might
affect
antivir
activ
peptid
therefor
assess
whether
new
peptid
would
possess
broadspectrum
antimerscov
activ
use
pseudotyp
smediat
merscov
mutant
site
infect
target
cell
presenc
peptid
shown
figur
c
similar
three
peptid
could
effect
inhibit
infect
caus
two
pseudotyp
merscov
mutant
exhibit
potent
inhibitori
activ
either
howev
peptid
exhibit
obviou
inhibit
vesicular
stomat
viru
vsv
g
proteinmedi
pseudoviru
infect
concentr
figur
result
timeofremov
assay
indic
inhibitori
activ
peptid
merscov
pseudoviru
associ
bind
peptid
target
cell
figur
besid
peptid
high
concentr
show
cytotox
figur
result
suggest
fusion
inhibitori
activ
peptid
nonspecif
interact
viral
cellular
membran
protein
cytotox
target
cell
earli
jiang
et
al
wild
et
al
identifi
potent
fusion
inhibitori
peptid
deriv
chr
domain
later
renam
subsequ
numer
report
show
peptid
deriv
domain
class
membran
fusion
protein
envelop
virus
respiratori
syncyti
viru
rsv
paramyxovirus
simian
viru
nipah
viru
mous
hepat
viru
mhv
exhibit
inhibitori
activ
correspond
virus
similarli
previou
work
found
deriv
merscov
region
deriv
sarscov
region
exhibit
effect
fusioninhibitori
activ
merscov
sarscov
respect
howev
inhibitori
activ
sarscov
inhibitori
activ
merscov
suggest
peptid
lack
crossinhibitori
activ
thu
limit
develop
broad
hcov
fusion
inhibitor
best
knowledg
herein
report
first
time
batcov
peptid
name
could
success
crossbind
form
stabl
peptid
especi
exhibit
potent
inhibitori
activ
merscov
smediat
fusion
effect
block
pseudotyp
merscov
infect
indic
exist
potent
fusion
inhibitor
merscov
infect
natur
batcov
region
previous
report
fusion
core
region
import
format
therefor
herein
design
peptid
contain
helic
region
peptid
exhibit
antivir
activ
merscov
infect
apart
helic
previou
studi
also
suggest
n
ctermin
tail
region
could
import
inhibitori
activ
peptid
inde
three
peptid
possess
differ
termin
tail
region
exhibit
variou
antivir
activ
merscov
infect
hand
locat
region
merscov
region
howev
higher
helic
tm
valu
complex
complex
may
contribut
higher
antimerscov
activ
interestingli
valu
helic
tm
complex
equal
lower
show
potent
antivir
activ
compar
either
precis
antivir
mechan
worth
elucid
futur
studi
specul
answer
might
lie
ctermin
tail
belong
tryptophan
trp
rich
membran
proxim
extern
region
mper
best
exemplifi
sarscov
mperderiv
peptid
interact
intern
fusion
peptid
inhibit
format
mperifp
heterom
put
quaternari
structur
extend
function
membran
fusion
moreov
mperderiv
peptid
could
directli
inhibit
sarscov
entri
exhibit
similar
potent
inhibitori
activ
like
block
merscov
format
disturb
interact
mper
ifp
merscov
infect
clearli
constitut
novel
strategi
develop
merscov
peptid
fusion
inhibitor
bispecif
target
ifp
consist
report
unlik
chr
peptid
nhr
peptid
deriv
envelop
virus
class
membran
fusion
protein
eg
sarscov
merscov
low
activ
inhibit
format
fusion
viral
infect
mainli
peptid
tend
aggreg
physiolog
solut
found
also
exhibit
fusion
inhibitori
activ
possibl
reason
describ
nonetheless
previous
report
conjug
fibritin
trimer
domain
foldon
fd
nhr
peptid
deriv
make
nhr
peptid
fold
stabl
solubl
trimer
coiledcoil
potent
fusion
inhibitori
activ
use
similar
approach
construct
merscov
fusion
inhibitori
activ
respect
coronaviru
close
relat
merscov
recogn
bind
receptor
human
importantli
risk
infect
human
could
sharpli
increas
simpl
induct
two
mutant
protein
howev
spars
inform
fusion
core
current
avail
effect
fusion
inhibitor
report
base
structur
merscov
fusion
core
design
peptid
interact
mimic
format
process
region
henc
studi
contribut
better
understand
mechan
infect
provid
inform
develop
peptid
fusion
inhibitor
event
cross
speci
barrier
infect
human
summari
develop
seri
batcovderiv
peptid
fusion
inhibitor
includ
interact
mer
form
highli
stabl
mimick
format
merscov
structur
addit
peptid
especi
exhibit
potent
inhibitori
activ
merscov
infect
indic
batcov
peptid
promis
candid
develop
clinic
agent
merscov
infect
